Independent report: JCVI update on advice for COVID-19 vaccination of children aged 5 to 11

Independent report: JCVI update on advice for COVID-19 vaccination of children aged 5 to 11 JCVI advises a non-urgent offer of two 10 mcg doses of the Pfizer-BioNTech COVID-19 vaccine (Comirnaty®) to children aged 5 to 11 years of age who are not in a clinical risk group.

The intention of this offer is to increase the immunity of vaccinated individuals against severe COVID-19 in advance of a potential future wave of COVID-19. Department of Health and Social Care

See also: 

• Government response: Health Secretary statement on COVID-19 vaccines for five- to 11-year-olds Department of Health and Social Care
• Guidance: COVID-19 vaccination: resources for children aged 5 to 11 years UK Health Security Agency
• JCVI updates advice on vaccinations for 5 to 11 age group UK Health Security Agency